Left ventricular hypertrophy: differential diagnosis
Abstract
There are some imaging methods for the diagnosis of left ventricular hypertrophy. Such as echocardiography, computed tomography, magnetic resonance imaging. These methods help to identify changes at different stages, evaluate the prognosis, stratify the risk and differential diagnosis.
The left ventricle hypertrophy is a condition that may be due to physiological adaptation due to overload. For example, in patients with arterial hypertension, in athletes, and so on. Left ventricle hypertrophy may also be associated with a change in the actual structure: for example, with hypertrophic cardiomyopathy.
Signs of left ventricle hypertrophy by echocardiography are a very significant predictor of mortality in patients with arterial hypertension in the general population. The presence of left ventricle hypertrophy by echocardiography is a high cardiovascular risk for the patient.
It is important to diagnose diseases with a high risk of sudden cardiac death on time. One of these diseases is hypertrophic cardiomyopathy. A clinical diagnosis of hypertrophic cardiomyopathy is impossible without visualization. Therefore, the European Association of Cardiovascular Imaging recommends a multimodal approach in examining patients with hypertrophic cardiomyopathy.
Сomputed tomography, echocardiography, and magnetic resonance imaging are used to diagnose which patient’s hypertrophy is pathological or physiological. The choice of which method to use depends on the diagnostic task, and also on the specific advantages and disadvantages of the method. Different visualization methods should be considered complementary, not competing. It is also important to choose a particular imaging technique given its diagnostic value, availability, benefits, risks and costs.
Downloads
References
Rukovodstvo po kardiologii. Pod red. V.N. Kovalenko. K.: Morion; 2008. 1424 р. (in Russian)
Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). European Heart Journal - Cardiovascular Imaging. 2015;16(6):577-605. doi: 10.1093/ehjci/jev076.
Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. European Heart Journal - Cardiovascular Imaging. 2015;16(3):280. doi: 10.1093/ehjci/jeu291.
The multi-modality cardiac imaging approach to the Athlete’s heart: an expert consensus of the European Association of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging. 2015;16(4):353. PMID: 25681828. DOI:10.1093/ehjci/jeu323
Rekomendacii z diagnostyky ta likuvannja gipertrofichnoi kardiomiopatii. Asociacija kardiologiv Ukrainy. K.: Moryon; 2014. 24 p. (in Ukrainian)
Rybakova MK, Alehin MN, Mitkov VV. Prakticheskoe rukovodstvo po ultrazvukovoj diagnostike. M.: Vidarzh; 2008. 512 p. (in Russian)
Sercevo-sudinnі zahvorjuvannja. Klasifіkacіja, standarti dіagnostiki ta lіkuvannja. Za red. prof. VM Kovalenka, prof. M І Lutaja, prof. JuM Sіrenka. K.: Asocіacіja kardіologіv Ukraini; 2014. 128 p. (in Ukrainian)
ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 2013;34:2159-219. doi:10.1093/ eurheartj/eht151
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardio-graphy and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70. doi: 10.1093/ehjci/jev014.
ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. https://doi.org/10.1093/eurheartj/ehy339
The EACVI Echo Handbook. Еuropean Society of Cardiology; 2016.
ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-79. doi: 10.1093/eurheartj/ehu284.
Fejgenbaum H. Jehokardiografija. Per s angl. Pod red. VV Mitkova. M.: Vidar; 1999. 512 p. (in Russian)
Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI. Am J Roentgenol. 2007;189:1335-43. PMID: 18029869. DOI:10.2214/AJR.07.2286
Bergey PD, Axel L. Focal hypertrophic cardiomyopathy simulating a mass: MR tagging , or correct diagnosis. Am J Roentgenol. 2000;174:242-4. PMID:10628486. DOI: 10.2214/ajr.174.1.1740242
Aquaro GD, Positano V, Pingitore A et al. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2010;12:21. PMID: 20374627. PMCID: PMC2867984. doi: 10.1186/1532-429X-12-21.
Vserossijskoe nauchnoe obshhestvo kardiologov. Nacionalnye rekomendacii po dopusku k zanjatijam sportom i uchastiju v sorevnovanijah sportsmenov s otklonenijami so storony serdechno-sosudistoj sistemy. Racionalnaja farmakoterapija v kardiologii. 2011;7(6) (suppl):2-60. (in Russian)
Rawlins J, Bhan A, Sharma S. Left ventricular hypertrophy in athletes. Eur J Echocardiogr. 2009;10:350-6. doi: 10.1093/ejechocard/jep017.
Nagueh S, Smiseth O, Appleton C et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.

This work is licensed under a Creative Commons Attribution 4.0 International License.